期刊文献+

腹腔镜手术在复发性卵巢癌中的应用价值 被引量:6

下载PDF
导出
摘要 目的:对比分析腹腔镜和开腹手术在复发性卵巢癌中的治疗效果,探讨腹腔镜手术在复发性卵巢癌中的应用价值。方法:2005年1月至2012年12月在我院经腹腔镜探查发现复发性卵巢恶性肿瘤26例,其中14例经腹腔镜行肿瘤细胞减灭术,12例在腹腔镜探查后转开腹手术行肿瘤细胞减灭术。对比分析两组手术时间、术中出血量、住院时间、术后并发症、无进展生存期(PFS)、2年生存率等。结果:与开腹手术组比较,腹腔镜手术组的手术时间及住院时间更短,术中出血量更少,术后并发症发生率更低,差异均有统计学意义(P<0.05)。两组患者PFS及2年生存率差异无统计学意义(P>0.05)。结论:腹腔镜手术与开腹手术在复发性卵巢癌中的治疗效果相似,且腹腔镜手术时间更短,具有创伤小及术后恢复快的优势。
作者 蒲玉华
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2015年第9期711-713,共3页 Journal of Practical Obstetrics and Gynecology
  • 相关文献

参考文献10

  • 1Ushijima K. Treatment for recurrent ovarian cancer-at first relapse[J].J Oncol,2010,2010:497429.
  • 2Bristow RE. Surgical standards in the management of ovarian cancer[J].Curr Opin Oncol,2000,12(5) :474 -480.
  • 3Burke TW, Morris M. Secondary cytoreductive surgery for ovariancancer[ J]. Obstet Gynecol Clin North Am,1994,21 ( 1 ) : 167 - 178.
  • 4Leitao MM,Kardos S,Barakat RR,et al. Tertiary cytoreduction in pa-tients with recurrent ovarian carcinoma[ J]. Gynecol Oncol,2004,95(2):181 -188.
  • 5Gungor M,Ortac F,Arvas M,et al. The role of secondary cy toreduc-tive surgery for recurrent ovarian cancer[ J]. Gynecol Oncol,2005,97(1):74-79.
  • 6Hoskins WJ,Mc Guire WP,Brady MF,et al. The effect of diameter oflargest residual disease on survival after primary cytoreductive surgeryin patients with suboptimal residual epithelial ovarian carcinoma[ J].Am J Obstet Gynecol,1994,170(4) :974 -980.
  • 7Tian WJ,Jiang R,Cheng X,et al. Surgery in recurrent epithelial ovari-an cancer: benefits on Survival for patients with residual disease of0. 1 - 1 cm after secondary cytoreduction [ J]. J Surg Oncol, 2010,101(3) :244 -250.
  • 8Bristow RE,Puri I,Chi DS. Cytoreductive surgery for recurrent ovari-an cancer : a meta-analysis [ J]. Gynecol Oncol’ 2009,112 ( 1 ) : 265-274.
  • 9Nezhat FR,De Noble SM,Liu CS,et al. The safety and efficacy of lap-aroscopic surgical staging and debulking of apparent advanced stageovarian,fallopian tube,and primary peritoneal cancers [ J ]. JSLS,2010,14(2) :155 -168.
  • 10Fanning J,Yacoub E,Hojat R. Laparoscopic-assisted cytoreduction forprimary advanced ovarian cancer:success,morbidity and survival[ J].Gynecol Oncol,2011,123(1 ) :47 -49.

同被引文献47

引证文献6

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部